RESUMEN
BACKGROUND: The prevalence of deep venous thrombosis (DVT) in patients with gastric cancer before surgery is unknown. This study aimed to clarify the risk factors for DVT of the lower extremities in patients with gastric cancer before surgery and to evaluate the usefulness of ultrasonographic screening for prevention of postoperative pulmonary thromboembolism (PTE). METHODS: Patients who had undergone lower-extremity venous ultrasonography before surgery for gastric cancer were retrospectively analyzed. Univariate and multivariate logistic regression analyses were performed to identify the predictors of DVT before surgery. Perioperative management of patients with DVTs and the incidence of postoperative PTE were investigated. RESULTS: Of the total 1140 patients, 86 had DVT preoperatively. On univariate analysis, the incidence of DVT was significantly higher with: female sex; age ≥80 years; PS ≥ 1 (vs. PS = 0); stage IV (vs. stages I-III); history of preoperative chemotherapy; and the presence of a central venous catheter (CVC). Multivariate logistic regression analysis demonstrated that sex, age ≥80 years, PS ≥ 1, history of preoperative chemotherapy, and the presence of CVC were significantly correlated with DVT before surgery. Postoperative PTE occurred in 2 patients with proximal DVT. No patients in whom DVT was not detected developed PTE. CONCLUSIONS: Female sex, older age, worse PS, the presence of CVC, and a history of preoperative chemotherapy were the independent risk factors for DVT. Routine lower-extremity venous ultrasonographic screening is useful for prevention of PTE because it can identify patients at high or low risk for PTE.
Asunto(s)
Complicaciones Posoperatorias/prevención & control , Embolia Pulmonar/diagnóstico por imagen , Neoplasias Gástricas/cirugía , Trombosis de la Vena/diagnóstico por imagen , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Incidencia , Modelos Logísticos , Extremidad Inferior/irrigación sanguínea , Masculino , Persona de Mediana Edad , Análisis Multivariante , Complicaciones Posoperatorias/epidemiología , Cuidados Preoperatorios/métodos , Prevalencia , Embolia Pulmonar/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Ultrasonografía/métodos , Trombosis de la Vena/epidemiologíaRESUMEN
BACKGROUND: Abdominal ultrasound is the most convenient modality for examining the morphology of the pancreas without physical stress. Steroid response is one of the key features of autoimmune pancreatitis; however, visualizing this response has not been evaluated using ultrasonography. METHODS: Thirty-three consecutive autoimmune pancreatitis cases were retrospectively investigated for pancreatic and extrapancreatic lesions by ultrasonography before steroid therapy (n=33) and at two weeks (n=28) and one month (n=19) after starting oral steroid treatment. RESULTS: Steroid treatment resulted in obvious shrinkage of the pancreatic lesion in 86% of the cases at two weeks and in 97% until one month. The maximum thickness of the pancreatic lesion was reduced from 28 to 22 mm in two weeks (P<0.0001), and pancreatic echographic findings improved in one month. Swelling of the peripancreatic lymph node was recognized in 48% and the aortic wall thickness in 12%, mostly reduced in two weeks (P=0.005). One case of definitive autoimmune pancreatitis revealed a steroid response only by following endoscopic retrograde cholangiopancreatography but not by ultrasonography or computed tomography. CONCLUSIONS: Abdominal ultrasound revealed a steroid response in most cases of autoimmune pancreatitis within two weeks. Ultrasonography is suitable for initial confirmation of a steroid response; however, atypical cases showing insufficient response or not fulfilling criteria should undergo further examination.
Asunto(s)
Enfermedades Autoinmunes/diagnóstico por imagen , Enfermedades Autoinmunes/tratamiento farmacológico , Ganglios Linfáticos/diagnóstico por imagen , Pancreatitis/diagnóstico por imagen , Pancreatitis/tratamiento farmacológico , Esteroides/uso terapéutico , Anciano , Aorta/diagnóstico por imagen , Enfermedades Autoinmunes/sangre , Femenino , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Pancreatitis/sangre , Estudios Retrospectivos , Esteroides/administración & dosificación , UltrasonografíaRESUMEN
To study the mechanisms behind the suppression of gene expression in the early phase of Xenopus development (cleavage stage), we conducted in silico cloning of the Xenopus transcriptional repressor NC2alpha. A search of the GenBank EST database using human NC2alpha as a probe identified Xenopus mitotic phosphoprotein 30 (xMP30) as a prime candidate for Xenopus NC2alpha (xNC2alpha). Full-length cDNA sequencing showed that xNC2alpha/xMP30 had a 68.9% identity at the amino acid level with its human counterpart. Northern blotting showed that xNC2alpha existed abundantly as a maternal mRNA. After the fertilization, the expression of xNC2alpha rapidly increased and reached a maximum 3 h before midblastula transition (MBT). Then its expression gradually decreased toward the early neurula stage. The expression profile of xNC2alpha mRNA is compatible with that of xNC2beta, which is the other component of the Xenopus NC2 transcriptional repressor.